Positive news on University of Oxford’s coronavirus COVID-19 vaccine expected on July 16: Report
Amid the rising coronavirus COVID-19 circumstances in India and a number of other different international locations, positive information on preliminary trials of the University of Oxford’s potential coronavirus that has been licensed to AstraZeneca may very well be introduced on Thursday (July 16). ITV’s political editor Robert Peston mentioned that Phase III trials of the COVID-19 vaccine candidate started in June in Brazil. Peston mentioned, citing sources, that Phase III trials concerned hundreds of human volunteers,
“I am hearing there will be positive news soon (perhaps tomorrow) on initial trials of the Oxford Covid-19 vaccine that is backed by AstraZeneca,” Peston mentioned in a weblog publish.
“Apparently the vaccine is generating the kind of antibody and T-cell (killer cell) response that the researchers would hope to see. If the Oxford vaccine is proven effective, it could go into mass production as early as September,” he added.
Notably, a number of coronavirus COVID-19 vaccines are presently in numerous levels of testing worldwide, together with in Britain, China, the US and India.
On Wednesday (July 15), the Russian defence ministry had introduced that it had succeeded in creating a “safe” coronavirus vaccine following scientific trials on a bunch of volunteers. According to Russian defence ministry, 18 individuals had participated within the analysis and have been discharged with out “serious adverse events, health complaints, complications or side effects”.
US-based pharma large Moderna Inc mentioned on Tuesday that it’s planning to begin a late stage scientific trial for its COVID-19 vaccine candidate on or round July 27. Moderna is planning to conduct the trial at 87 research places throughout the US.
US authorities researchers mentioned on Tuesday that the COVID-19 vaccine developed by Moderna Inc produced antibodies to the coronavirus in all sufferers who participated in an preliminary security trial,
Indian pharma main Zydus introduced on Wednesday that it has began human research for its COVID-19 vaccine. Zydus is about to incorporate over 1,000 topics for human trials throughout a number of scientific research websites in India.
$(function() { return $("[data-sticky_column]").stick_in_parent({ parent: "[data-sticky_parent]" }); });
reset_scroll = function() { var scroller; scroller = $("body,html"); scroller.stop(true); if ($(window).scrollTop() !== 0) { scroller.animate({ scrollTop: 0 }, "fast"); } return scroller; };
window.scroll_it = function() { var max; max = $(document).height() - $(window).height(); return reset_scroll().animate({ scrollTop: max }, max * 3).delay(100).animate({ scrollTop: 0 }, max * 3); };
window.scroll_it_wobble = function() { var max, third; max = $(document).height() - $(window).height(); third = Math.floor(max / 3); return reset_scroll().animate({ scrollTop: third * 2 }, max * 3).delay(100).animate({ scrollTop: third }, max * 3).delay(100).animate({ scrollTop: max }, max * 3).delay(100).animate({ scrollTop: 0 }, max * 3); };
$(window).on("resize", (function(_this) { return function(e) { return $(document.body).trigger("sticky_kit:recalc"); }; })(this));
}).call(this);
} on_load_google_ad(); function sendAdserverRequest() { try { if (pbjs && pbjs.adserverRequestSent) return; googletag.cmd.push(function() { googletag.pubads().refresh(); }); } catch (e) {
googletag.cmd.push(function() { googletag.pubads().refresh(); }); } } setTimeout(function() { sendAdserverRequest(); }, 5000);
function on_load_fb_twitter_widgets(){ (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.9"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
window.twttr = (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0], t = window.twttr || {}; if (d.getElementById(id)) return t; js = d.createElement(s); js.id = id; js.src = "https://platform.twitter.com/widgets.js"; fjs.parentNode.insertBefore(js, fjs); t._e = []; t.ready = function(f) {
t._e.push(f); }; return t; }(document, "script", "twitter-wjs")); }
//setTimeout(function() { on_load_google_ad(); }, 5000); setTimeout(function() { on_load_fb_twitter_widgets(); }, 5000);
Source